Adam Laponis's most recent trade in Twist Bioscience Corp was a trade of 4,000 Common Stock done at an average price of $70 . Disclosure was reported to the exchange on May 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 29 May 2026 | 4,000 | 112,675 (0%) | 0% | 70 | 280,000 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 53.26 per share. | 21 May 2026 | 2,019 | 116,675 (0%) | 0% | 53.3 | 107,526 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 17 Apr 2026 | 4,000 | 118,694 (0%) | 0% | 60 | 240,000 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 14 Apr 2026 | 3,000 | 122,694 (0%) | 0% | 55 | 165,000 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.89 per share. | 09 Apr 2026 | 2,597 | 125,694 (0%) | 0% | 49.9 | 129,562 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.71 per share. | 23 Feb 2026 | 2,085 | 128,291 (0%) | 0% | 46.7 | 97,390 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 12 Feb 2026 | 7,000 | 130,031 (0%) | 0% | 50 | 350,000 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 13 Jan 2026 | 3,000 | 137,031 (0%) | 0% | 40 | 120,000 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.26 per share. | 09 Jan 2026 | 2,738 | 140,031 (0%) | 0% | 35.3 | 96,545 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.50 per share. | 21 Nov 2025 | 887 | 142,769 (0%) | 0% | 26.5 | 23,509 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2025 | 32,648 | 143,656 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 5,517 | 111,008 (0%) | 0% | 31.4 | 173,478 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2025 | 25,000 | 116,525 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.15 per share. | 08 Oct 2025 | 3,000 | 94,042 (0%) | 0% | 31.2 | 93,450 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.92 per share. | 08 Oct 2025 | 2,517 | 91,525 (0%) | 0% | 32.9 | 82,865 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.19 per share. | 06 Oct 2025 | 5,875 | 97,042 (0%) | 0% | 32.2 | 189,099 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.96 per share. | 21 Aug 2025 | 918 | 102,917 (0%) | 0% | 26.0 | 23,835 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.15 per share. | 09 Jul 2025 | 2,449 | 103,569 (0%) | 0% | 38.1 | 93,420 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.75 per share. | 21 May 2025 | 936 | 106,018 (0%) | 0% | 29.7 | 27,843 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.97 per share. | 09 Apr 2025 | 2,542 | 106,954 (0%) | 0% | 35.0 | 88,887 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 21 Feb 2025 | 918 | 109,496 (0%) | 0% | 44.2 | 40,554 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 43.26 per share. | 10 Jan 2025 | 5,886 | 110,096 (0%) | 0% | 43.3 | 254,646 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 26,745 | 115,982 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.61 per share. | 06 Nov 2024 | 4,160 | 89,237 (0%) | 0% | 44.6 | 185,557 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.61 per share. | 06 Nov 2024 | 4,160 | 89,237 (0%) | 0% | 44.6 | 185,557 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 20,000 | 93,397 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 41.81 per share. | 09 Oct 2024 | 856 | 73,397 (0%) | 0% | 41.8 | 35,791 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 48.91 per share. | 09 Jul 2024 | 842 | 73,602 (0%) | 0% | 48.9 | 41,185 | Common Stock |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.15 per share. | 09 Apr 2024 | 556 | 74,444 (0%) | 0% | 33.2 | 18,434 | Common Stock |
| Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 25,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 97,500 | 97,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Aug 2023 | 824 | 0 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 824 | 824 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.21 per share. | 15 Aug 2023 | 19 | 3,152 | - | 3.2 | 61 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.68 per share. | 17 May 2023 | 19 | 3,171 | - | 4.7 | 89 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.38 per share. | 17 Feb 2023 | 21 | 3,190 | - | 7.4 | 155 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 82,500 | 82,500 | - | - | Stock Option (Right to Buy) | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | 22 Nov 2022 | 4,995 | 64,222 | - | 0.5 | 2,498 | Common Stock | |
| Eargo Inc | Adam Laponis | Chief Financial Officer | 22 Nov 2022 | 525 | 0 | - | - | Subscription Rights (right to buy) | ||
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 17 Nov 2022 | 687 | 59,227 | - | 0.5 | 357 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. | 09 Mar 2022 | 714 | 60,271 | - | 1.6 | 1,107 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 4.01 per share. | 09 Mar 2022 | 608 | 61,408 | - | 4.0 | 2,438 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.01 per share. | 09 Mar 2022 | 423 | 60,985 | - | 4.0 | 1,696 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 09 Mar 2022 | 357 | 59,914 | - | 1.1 | 407 | Common Stock |
| Eargo Inc | Adam Laponis | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.54 per share. | 17 Aug 2021 | 359 | 62,016 | - | 24.5 | 8,809 | Common Stock |